Moderna posts surprise profit
With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Sarepta pulls plug on Duchenne exon-skipping drug
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Sarepta pulls plug on Duchenne exon-skipping drug
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*